This guideline aims to provide clinicians with a framework for the diagnosis, prevention, and monitoring of adult patients with kidney stones, based on the best available evidence in the published literature.
This document is the Spanish-language version of the American Urological Association (AUA) clinical practice guideline on the medical management of kidney stones in adults. It presents evidence-based statements covering patient evaluation, dietary therapies, pharmacological therapies, and follow-up monitoring.
The guideline was developed from a systematic review of the literature and supplementary searches conducted by the AUA. Each statement is classified as a Standard, Recommendation, or Option, with evidence strength graded A (high), B (moderate), or C (low), or presented as Clinical Principles and Expert Opinions when evidence is insufficient. This manual is written in Spanish.
Clinicians should recommend a fluid intake that produces a urine volume of at least 2.5 liters per day.
Patients with calcium stones and relatively elevated urinary calcium should limit sodium intake and consume 1,000–1,200 mg of dietary calcium per day.
A single 24-hour urine sample should be obtained within six months of starting treatment, and then once a year or more frequently depending on stone activity.
Thiazide diuretics are offered to patients with elevated urinary calcium and recurrent calcium stones; potassium citrate is offered to those with low or relatively low urinary citrate.